May 9, 2012
Two-Hour Session Will Feature Two Live Cases; Pooled Analysis of Bifurcation Stent System Will
Examine Evidence from Eight Clinical Studies
Durham, N.C. – Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced activities highlighting the latest experience with the TRYTON Side Branch Stent at EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions, taking place at the Palais des Congrès May 15-18, 2012 in Paris. Read More…
May 2, 2012
William A. Peck, MD, the Alan A. and Edith L. Wolff Distinguished Professor of Medicine and director of the Center for Health Policy at Washington University in St. Louis, was presented with the Washington University Eliot Society “Search” Award at the 45th annual dinner of the William Greenleaf Eliot Society May 1 at the Ritz-Carlton Hotel in Clayton, Mo. Read more
March 16, 2012
A $1 billion-plus deal between Boston Scientific Corp. and medical device firm Cameron Health Inc. is bringing a payout of more than $12 million to RiverVest Venture Partners and its investors. Read More
March 9, 2012
ST. LOUIS , MO- RiverVest Venture Partners today announced that Boston Scientific Corporation has exercised its option to acquire RiverVest portfolio company Cameron Health, Inc., a medical device innovator based in San Clemente, California.
Read More…
